Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

RUNX1 mRNA-containing nanomicelles prevent intervertebral disk degeneration in mice

March 5, 2019

Lupus Therapeutics collaborates with Takeda on phase I trial of TAK-079 for SLE

March 4, 2019

Bristol-Myers Squibb presents lysophospholipid S1P1 receptor agonists

March 4, 2019

Azetidine optimization leads to clinical candidate JTE-952 for rheumatoid arthritis

March 1, 2019

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Feb. 28, 2019

Nodthera patents NLRP3 inflammasome inhibitors

Feb. 28, 2019

Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb

Feb. 26, 2019

Bristol-Myers Squibb identifies TLR7/8/9 antagonists

Feb. 22, 2019

EZH2 inhibitors may be a means of treating scleroderma

Feb. 20, 2019

Topline results from Japanese confirmatory phase III study of ONO-5704 in knee osteoarthritis

Feb. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...